SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-017103
Filing Date
2020-08-07
Accepted
2020-08-07 20:12:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dmtp20200805_424b5.htm 424B5 637140
2 chart01.jpg GRAPHIC 32406
3 dmtp20191219_s3img001.gif GRAPHIC 5243
4 dmtp20200803_424b5img001.gif GRAPHIC 5028
5 dmtp20200803_424b5img002.gif GRAPHIC 14754
  Complete submission text file 0001437749-20-017103.txt   717842
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235775 | Film No.: 201086420
SIC: 2834 Pharmaceutical Preparations